Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

13 Oct 2023 16:56

RNS Number : 1307Q
Maven Income & Growth VCT PLC
13 October 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Joint Announcement by Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC

Offers for Subscription

13 October 2023

 

The Board of Directors of Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in each of the Companies to raise, in aggregate, up to £30 million including over-allotment facilities of up to, in aggregate, £10 million (before issue costs) (the "Offers" and each an "Offer").

The Companies have also published a joint Circular (the "Circular") seeking the approval of their respective shareholders for various matters, including obtaining shareholder approval of allotment and disapplication authorities in connection with the Offers and each Company giving notice of a General Meeting to be held on 9 November 2023 (the "General Meeting").

The Offers will open on 13 October 2023 and the deadline for receipt of applications is 9.00 am on 5 April 2024 in relation to the tax year 2023/24 and 5.00 pm on 26 April 2024 in relation to the tax year 2024/25. The Offers will close on 1 May 2024 unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant Board to no later than 11 October 2024. 

Each Offer is conditional on the passing of certain resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 13 October 2023 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of each Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the fee applying in certain cases (for instance, early applications under the Offers). Maven, as the investment manager of each Company, is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven Capital Partners LLP on 0141 306 7400. A downloadable version of the Securities Note will also be available from the Maven website: mavencp.com/vctoffer.

Copies of the Prospectus and Circular are available, free of charge, from Maven Capital Partners UK LLP at Kintyre House, 205 West George Street, Glasgow G2 2LW.

Copies of the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for viewing online at the following website address: data.fca.org.uk/#/nsm/nationalstoragemechanism.

Any enquiries in respect of the Offers should be directed to:

Maven Capital Partners UK LLPTelephone: 0141 306 7400

E-mail: enquiries@mavencp.com

The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

Notes

 

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIKZMMGKFZGFZM
Date   Source Headline
15th Apr 20153:12 pmRNSResult of AGM
13th Apr 20153:11 pmRNSIssue of Equity
4th Mar 20155:16 pmRNSAnnual Financial Report
26th Feb 201512:09 pmRNSIssue of Equity
26th Feb 201511:24 amRNSDirector/PDMR Shareholding
20th Feb 20152:47 pmRNSIssue of Equity
11th Feb 201511:40 amRNSNet Asset Value(s)
5th Feb 20155:00 pmRNSStatement re Offers for Subscription
3rd Feb 20153:07 pmRNSStatement re Offers for Subscription
30th Jan 20154:53 pmRNSStatement re Offers for Subscription
20th Jan 20159:48 amRNSStatement re Offers for Subscription
9th Jan 201510:17 amRNSDirector Declaration
7th Jan 20152:11 pmRNSStatement re Offers for Subscription
6th Nov 20145:23 pmRNSTransaction in Own Shares
5th Nov 20142:30 pmRNSTransaction in Own Shares
4th Nov 20144:46 pmRNSTransaction in Own Shares
4th Nov 20144:41 pmRNSDirector/PDMR Shareholding
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
10th Oct 20142:46 pmRNSInterim Management Statement
3rd Oct 20144:23 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
26th Aug 20145:07 pmRNSTransaction in Own Shares
13th Aug 20144:41 pmRNSTransaction in Own Shares
12th Aug 20143:36 pmRNSTransaction in Own Shares
11th Aug 20144:22 pmRNSTransaction in Own Shares
4th Aug 20145:26 pmRNSDirector/PDMR Shareholding
31st Jul 20143:06 pmRNSDirector/PDMR Shareholding
31st Jul 20143:03 pmRNSTransaction in Own Shares
29th Jul 20143:44 pmRNSDirector/PDMR Shareholding
29th Jul 201412:37 pmRNSHalf Yearly Report
4th Jul 20144:31 pmRNSReplacement re Issue of Equity
2nd Jul 20149:50 amRNSIssue of Equity
28th May 20145:09 pmRNSOffer for Subscription Update
30th Apr 20142:25 pmRNSDirectorate Change
30th Apr 20142:18 pmRNSAGM Results
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:46 pmRNSOffer for Subscription - Supplementary Prospectus
15th Apr 201410:09 amRNSInterim Management Statement
7th Apr 20144:16 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:29 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
4th Mar 20143:56 pmRNSAnnual Financial Report
13th Feb 201410:42 amRNSDirector/PDMR Shareholding
10th Feb 20146:05 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:20 pmRNSIssue of Equity
3rd Jan 201411:09 amRNSDirectorate Change
27th Nov 20132:04 pmRNSReplacement Result of General Meeting
27th Nov 20131:33 pmRNSResult of EGM
24th Oct 20136:11 pmRNSOffer for Subscription
17th Oct 20132:39 pmRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.